Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Zito

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
JAMA Pediatrics|July 11, 2017
Extending the Social Justice Call to Treatment OutcomesJulie M Zito
Medical Care|October 11, 2012
Pharmaceuticals and the health of the public: use, safety, cost, access, ethics, and qualityJulie M Zito
Psychotherapy and Psychosomatics|August 18, 2015
High-Dose Benzodiazepine Use among Long-Term Users: When Will We Ever Learn?Julie M Zito
Journal of Child and Adolescent Psychopharmacology|August 19, 2017
Response to Adesman and Blaufox re: "Stimulants and Pediatric Cardiovascular Risk"Julie M Zito, Mehmet Burcu
Medical Care|November 16, 2016
For-profit Uses of Real-World Data: What Would Frances Kelsey Do?Julie M Zito, Peter Doshi
Journal of Child and Adolescent Psychopharmacology|June 4, 2016
Stimulants and Pediatric Cardiovascular RiskJulie M Zito, Mehmet Burcu
The Journal of Nervous and Mental Disease|July 31, 2013
Number needed to harm: its limitations in psychotropic drug safety researchDaniel J Safer, Julie M Zito
Medical Care|September 21, 2017
2016 Medical Care Student Award PapersJulie M Zito, Linda D Green
The Journal of Nervous and Mental Disease|November 2, 2013
Number needed to harmDaniel J Safer, Julie M Zito
JAMA|March 4, 2015
Medicaid prior authorization policies for pediatric use of antipsychotic medicationsIan Schmid, Mehmet Burcu, Julie M Zito
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
JAMA Pediatrics|July 11, 2017
Extending the Social Justice Call to Treatment OutcomesJulie M Zito
Medical Care|October 11, 2012
Pharmaceuticals and the health of the public: use, safety, cost, access, ethics, and qualityJulie M Zito
Psychotherapy and Psychosomatics|August 18, 2015
High-Dose Benzodiazepine Use among Long-Term Users: When Will We Ever Learn?Julie M Zito
Journal of Child and Adolescent Psychopharmacology|August 19, 2017
Response to Adesman and Blaufox re: "Stimulants and Pediatric Cardiovascular Risk"Julie M Zito, Mehmet Burcu
Medical Care|November 16, 2016
For-profit Uses of Real-World Data: What Would Frances Kelsey Do?Julie M Zito, Peter Doshi
Journal of Child and Adolescent Psychopharmacology|June 4, 2016
Stimulants and Pediatric Cardiovascular RiskJulie M Zito, Mehmet Burcu
The Journal of Nervous and Mental Disease|July 31, 2013
Number needed to harm: its limitations in psychotropic drug safety researchDaniel J Safer, Julie M Zito
Medical Care|September 21, 2017
2016 Medical Care Student Award PapersJulie M Zito, Linda D Green
The Journal of Nervous and Mental Disease|November 2, 2013
Number needed to harmDaniel J Safer, Julie M Zito
JAMA|March 4, 2015
Medicaid prior authorization policies for pediatric use of antipsychotic medicationsIan Schmid, Mehmet Burcu, Julie M Zito
Pageof 6